CENTAURUS FINANCIAL, INC. – Eli Lilly and Company Transaction History
CENTAURUS FINANCIAL, INC. portfolio value:
$1.25M
portfolio value
CENTAURUS FINANCIAL, INC. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +13.62% | 464 shares | 147K | $323.35 | 3.87K |
Q2 2022 | share | Increase | +47.15% | 1.09K shares | 442K | $324.23 | 3.40K |
Q1 2022 | share | Decrease | -0.34% | -8 shares | 21K | $286.37 | 2.31K |
Q4 2021 | share | Increase | +17.31% | 343 shares | 184K | $277.25 | 2.32K |
Q3 2021 | share | Increase | 0.00% | 1.98K shares | 458K | $230.3 | 1.98K |
Q2 2021 | share | Decrease | -100.00% | -616 shares | -115K | $228.04 | 0 |
Q1 2021 | share | Increase | 0.00% | 616 shares | 115K | $184.81 | 616 |
Q2 2018 | share | Increase | +103.40% | 3.15K shares | 294K | $79.72 | 6.21K |
Q1 2018 | share | Increase | 0.00% | 3.05K shares | 236K | $71.78 | 3.05K |